Delivery Order SPE2DB22D2211-SPE2DB25FRHCV
Award Date
10/17/24
Potential Completion Date
10/18/24
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,597.70 firm fixed-price delivery order is for the supply of ONTRUZANT 150 MG VIALS, a medical product, with a completion date of October 29, 2024. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ONTRUZANT 150 MG VIALS, a medical product, with a ceiling value of $5,468.75 and a completion date of June 16, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The $10,566.04 Firm Fixed Price Delivery Order is for the provision of ONTRUZANT 420 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of June 4, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00...
The Department of Defense (DoD) Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,196,108 units of ONTRUZANT 420 mg vials. The $38,690.35 contract has a completion date of December 29, 2023. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that provides pharmaceutical products and medical supplies to DLA Troop Support Medical...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Medical Supply Chain. The $5,621.75 firm fixed-price contract is for the delivery of ONTRUZANT 150 MG VIALS, a pharmaceutical product, with a performance period through May 12, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution and services company. The contract is for the delivery of 150 mg vials of the pharmaceutical product ONTRUZANT, with a ceiling value of $16,458.59 and a completion date of April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor for this award,...
This federal contract award, with the ID SPE2DB22D2206|SPE2DB24FGS37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is for the delivery of ONTRUZANT 420 MG VIALS, with a ceiling value of $49,864.36 and a period of performance through April 17, 2024. This award is not associated with any set-aside designation. Amerisourcebergen, through its Corporate Office...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $37,905.13, is for the delivery of ONTRUZANT 150 MG VIALS medical supplies. The contract was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as...
The Defense Logistics Agency awarded a $5,257.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562002953 ONTRUZANT 150 MG VIALS. The prime contractor, Amerisourcebergen Drug Corporation, will deliver the requested pharmaceutical products from its Conshohocken, Pennsylvania facility to the Defense Logistics Agency by August 31, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and supply chain to support the military...
This federal contract award is for the delivery of PRIORIX VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $6,047.88 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of December 19, 2024 and was awarded on December 18, 2024. This delivery order is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...